The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Regulatory News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.70
Ask: 3.90
Change: 0.15 (4.11%)
Spread: 0.20 (5.405%)
Open: 3.65
High: 3.80
Low: 3.65
Prev. Close: 3.65
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

25 Jun 2007 11:36

Fabian Romania Property Fund Ltd25 June 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or "Fabian") Fabian Romania acquires a 50 per cent. interest in a residential developmentsite to build 250 apartments in Timisoara for €4.7 million Fabian Romania is pleased to announce that it has purchased 50 per cent. of adevelopment company owning a 1.1 hectare site in north Timisoara. The equityconsideration amounts to approximately €1 million. The land area totals approximately 11,000 square metres and has urban zoningapproval to build over 250 apartments (subject to building permits) comprisingover 30,000 square metres of residential development space. Coltex, theco-shareholder holding the other 50% interest, has entered into a partnershipagreement with Fabian. Coltex will also be the development manager and has aknown track record, having developed and sold the successful Banu Antonachebuilding to Fabian in late 2005. Timisoara is Romania's third largest city with a population of over 300,000 andis located in the West close to the Hungarian border. The Investment Managerbelieves the city has attractive characteristics for supply of modernresidential apartments. The purchase price for the land including acquisition expenses was €4.7 million.This equates to around €427 per square metre for the land and €157 per builtsquare metre overground, assuming 30,000 square metres. The development companyhas already secured and fully drawdown on a land finance facility from BancaRomaneasca for €3.6 million. Including near term working capital needs, thisleaves an initial net equity requirement of approximately €1 million for Fabian. Responsible for the acquisition, Mark Owen, Property Director of Fabian Capital,Fabian Romania's investment adviser said: "This is the first investment for Fabian outside Bucharest and our secondresidential scheme. The purchase price for the land is extremely attractiverelative to comparable plots in Bucharest. We are also happy to have enteredinto a new partnership with Coltex for this development. Whilst it is clearTimisoara is in its infancy within the development process, strong indicationsexist that the residential sector is very undersupplied and that demand existsfor good, mid market apartments against a background of increasing prices." For Comments: Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLPJames Lewis +44 20 7936 3000 Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn
9th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 202311:05 amRNSSecond Price Monitoring Extn
9th Jan 202311:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSHalf-year Report
24th Nov 20227:00 amRNSNotice of Results
31st Oct 20221:47 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSBlock admission six monthly return
23rd Sep 202211:44 amRNSResult of AGM
20th Sep 20221:36 pmRNSDirector/PDMR Shareholding
15th Sep 20223:41 pmRNSGrant of options
14th Sep 20222:05 pmRNSSecond Price Monitoring Extn
14th Sep 20222:01 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSGrant of options
1st Sep 20227:00 amRNSNotice of AGM and Director change
23rd Aug 20227:00 amRNSFinal Results
9th Aug 20227:00 amRNSBispecific designs patent application
5th Aug 20224:41 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSAppointment of Chief Executive Officer
6th May 20227:00 amRNSTrading update
1st Apr 20227:00 amRNSBlock admission six monthly return
14th Mar 20227:00 amRNSUpdate on Board changes
28th Feb 20227:00 amRNSDirector changes
22nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSDirectorate Change
10th Feb 202212:49 pmRNSStmnt re Share Price Movement
14th Jan 20227:00 amRNSFormation of New Scientific Advisory Panel
11th Jan 20221:26 pmRNSHolding(s) in Company
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSExercise of share options and total voting rights
14th Dec 20217:00 amRNSExercise of share options and total voting rights
6th Dec 20217:00 amRNSHalf-year Report
2nd Dec 20217:00 amRNSUpdate on R&D
17th Nov 202110:00 amRNSNotice of Results
19th Oct 20214:25 pmRNSGrant of options
7th Oct 20214:40 pmRNSSecond Price Monitoring Extn
7th Oct 20214:35 pmRNSPrice Monitoring Extension
7th Oct 20212:06 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202111:06 amRNSSecond Price Monitoring Extn
7th Oct 202111:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSNew contract win
27th Sep 20217:00 amRNSTotal Voting Rights
24th Sep 202112:00 pmRNSResult of AGM
24th Sep 20217:00 amRNSAGM Statement
1st Sep 20217:00 amRNSNotice of AGM
31st Aug 20215:00 pmRNSTotal Voting Rights
24th Aug 20217:00 amRNSCollaboration with Eurofins Discovery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.